SCHEMBL29475704

SCHEMBL29475704

N[C@@H](Cc1ccccc1S(=O)(=O)O)C(=O)O

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC7A5 Q01650 3/20 0.53
PKM P14618 2/20 0.53
ALPI P09923 1/20 0.53
PTGS1 P23219 1/20 0.53
XIAP P98170 1/20 0.53
NOS3 P29474 3/20 0.53
NOS1 P29475 3/20 0.53
NOS2 P35228 3/20 0.53
KYNU Q16719 2/20 0.50
MAPT P10636 3/20 0.48
KDM4E B2RXH2 2/20 0.48
MEN1 O00255 2/20 0.48
LMNA P02545 2/20 0.48
BLM P54132 2/20 0.48
PMP22 Q01453 2/20 0.48
KMT2A Q03164 2/20 0.48
HIF1A Q16665 2/20 0.48
MPO P05164 1/20 0.48
TSHR P16473 1/20 0.48
USP2 O75604 2/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1984486 1.00 SLC7A5 (0.53) SLC7A5PKMALPIPTGS1XIAP
SCHEMBL1984487 1.00 SLC7A5 (0.53) SLC7A5PKMALPIPTGS1XIAP
SCHEMBL19900184 0.85 NOS3 (0.54) SLC7A5PKMALPIPTGS1XIAP
SCHEMBL19900181 0.85 NOS3 (0.54) SLC7A5PKMALPIPTGS1XIAP
SCHEMBL707080 0.82 MYC (0.41) SLC7A5PKMALPIPTGS1XIAP
SCHEMBL13971424 0.82 SLC7A5 (0.69) SLC7A5PKMALPIPTGS1XIAP
SCHEMBL9164980 0.82 SLC7A5 (0.69) SLC7A5PKMALPIPTGS1XIAP
Hydrochloric Acid SCHEMBL9169793 0.80 SLC7A5 (0.67) SLC7A5PKMALPIPTGS1XIAP
SCHEMBL5833053 0.80 HSD17B10 (0.51) SLC7A5PKMALPIPTGS1XIAP
SCHEMBL5833049 0.80 HSD17B10 (0.51) SLC7A5PKMALPIPTGS1XIAP

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4117732-A1 INTERLEUKIN-2 POLYPEPTIDE CONJUGATES AND METHODS OF USE THEREOF Ambrx, Inc. (US) 2023-01-18 EP claimed
EP-4199968-A1 ANTIBODY-TLR AGONIST CONJUGATES, METHODS AND USES THEREOF Ambrx, Inc. (US) 2023-06-28 EP disclosed
EP-4117732-A1 INTERLEUKIN-2 POLYPEPTIDE CONJUGATES AND METHODS OF USE THEREOF Ambrx, Inc. (US) 2023-01-18 EP disclosed
WO-2022040596-A1 ANTIBODY-TLR AGONIST CONJUGATES, METHODS AND USES THEREOF AMBRX, INC. (US) 2022-02-24 WO disclosed